AACB
Valuation N/A
Artius II Acquisition Inc.
Price$10.52
Model IV—
P/IV—
Limited data — see page
AACBR
Valuation N/A
Artius II Acquisition Inc.
Price$0.19
Model IV—
P/IV—
Limited data — see page
AACG
Valuation N/A
ATA Creativity Global
Price$1.04
Model IV—
P/IV—
Market implies +24.4%/yr
vs model +4.8% · above model
AACI
Valuation N/A
Armada Acquisition Corp. III
Price$10.00
Model IV—
P/IV—
Limited data — see page
AACO
Valuation N/A
Abony Acquisition Corp. I
Price$9.95
Model IV—
P/IV—
Limited data — see page
AACP
Valuation N/A
Apogee Acquisition Corp
Price$9.97
Model IV—
P/IV—
Limited data — see page
AAME
Undervalued
ATLANTIC AMERICAN CORP
Price$1.71
Model IV$2.38
P/IV0.91
Discount 28%
Return to IV: +39.0%
Market implies -19.6%/yr
vs model +2.0% · below model
AARD
Valuation N/A
Aardvark Therapeutics, Inc.
Price$5.70
Model IV—
P/IV—
Limited data — see page
ABLV
Deep Overvalued
Able View Global Inc.
Price$1.19
Model IV$0.40
P/IV2.75
Premium +198%
Return to IV: -66.4%
Market implies +14.6%/yr
vs model +3.0% · above model
ABOS
Valuation N/A
Acumen Pharmaceuticals, Inc.
Price$2.74
Model IV—
P/IV—
Limited data — see page
ABTC
Deep Overvalued
American Bitcoin Corp.
Price$0.56
Model IV$0.31
P/IV3.59
Premium +79%
Return to IV: -44.0%
Market implies +14.8%/yr
vs model +50.0% · below model
ABTS
Deep Undervalued
Abits Group Inc
Price$1.17
Model IV$3.57
P/IV0.23
Discount 67%
Return to IV: +205.1%
Market implies -18.4%/yr
vs model +46.0% · below model
ABVC
Valuation N/A
ABVC BIOPHARMA, INC.
Price$1.80
Model IV—
P/IV—
Market implies +72.0%/yr
vs model +2.0% · above model
ABVE
Valuation N/A
Above Food Ingredients Inc.
Price$0.11
Model IV—
P/IV—
Limited data — see page
ACAA
Valuation N/A
Averin Capital Acquisition Corp.
Price$10.20
Model IV—
P/IV—
Limited data — see page
ACB
Valuation N/A
AURORA CANNABIS INC
Price$2.84
Model IV—
P/IV—
Limited data — see page
ACCL
Undervalued
Acco Group Holdings Ltd
Price$1.72
Model IV$2.39
P/IV0.63
Discount 28%
Return to IV: +38.7%
Market implies +1.8%/yr
vs model +12.2% · below model
ACCS
Overvalued
ACCESS Newswire Inc.
Price$6.89
Model IV$5.66
P/IV1.14
Premium +22%
Return to IV: -17.8%
Market implies -6.9%/yr
vs model +2.0% · below model
ACET
Valuation N/A
Adicet Bio, Inc.
Price$9.00
Model IV—
P/IV—
Limited data — see page
ACFN
Deep Overvalued
ACORN ENERGY, INC.
Price$16.89
Model IV$11.21
P/IV1.52
Premium +51%
Return to IV: -33.6%
Market implies +11.0%/yr
vs model +11.7% · in line
ACGC
Valuation N/A
ACP Holdings Acquisition Corp.
Price$9.96
Model IV—
P/IV—
Limited data — see page
ACH
Deep Undervalued
ACCENDRA HEALTH INC/VA/
Price$3.59
Model IV$9.86
P/IV0.29
Discount 64%
Return to IV: +174.7%
Market implies -18.7%/yr
vs model +2.0% · below model
ACIU
Valuation N/A
AC Immune SA
Price$2.51
Model IV—
P/IV—
Limited data — see page
ACNT
Overvalued
ASCENT INDUSTRIES CO.
Price$15.26
Model IV$12.11
P/IV1.12
Premium +26%
Return to IV: -20.6%
Market implies -1.8%/yr
vs model +0.0% · in line
ACOG
Valuation N/A
Alpha Cognition Inc.
Price$7.89
Model IV—
P/IV—
Market implies +28.3%/yr
vs model +15.0% · above model
ACON
Valuation N/A
Aclarion, Inc.
Price$3.09
Model IV—
P/IV—
Market implies +34.6%/yr
vs model +5.9% · above model
ACONW
Deep Overvalued
Aclarion, Inc.
Price$0.02
Model IV$0.01
P/IV3.13
Premium +131%
Return to IV: -56.7%
Market implies +12.5%/yr
vs model +2.0% · above model
ACP
Valuation N/A
abrdn Income Credit Strategies Fund
Price$5.28
Model IV—
P/IV—
Limited data — see page
ACR
Deep Overvalued
ACRES Commercial Realty Corp.
Price$18.00
Model IV$8.28
P/IV2.46
Premium +117%
Return to IV: -54.0%
Market implies +10.7%/yr
vs model +3.0% · above model
ACRE
Deep Undervalued
Ares Commercial Real Estate Corp
Price$4.52
Model IV$6.70
P/IV0.74
Discount 33%
Return to IV: +48.2%
Market implies -7.6%/yr
vs model +1.0% · below model
ACRV
Valuation N/A
Acrivon Therapeutics, Inc.
Price$1.72
Model IV—
P/IV—
Limited data — see page
ACTG
Deep Overvalued
ACACIA RESEARCH CORP
Price$4.54
Model IV$0.99
P/IV2.54
Premium +357%
Return to IV: -78.1%
Market implies +20.8%/yr
vs model +3.0% · above model
ACTU
Valuation N/A
ACTUATE THERAPEUTICS, INC.
Price$1.52
Model IV—
P/IV—
Limited data — see page
ACU
Deep Overvalued
ACME UNITED CORP
Price$47.61
Model IV$16.96
P/IV2.49
Premium +181%
Return to IV: -64.4%
Market implies +14.5%/yr
vs model +3.2% · above model
ACV
Valuation N/A
Virtus Diversified Income & Convertible Fund
Price$28.03
Model IV—
P/IV—
Limited data — see page
ACXP
Valuation N/A
Acurx Pharmaceuticals, Inc.
Price$1.60
Model IV—
P/IV—
Limited data — see page
ADAC
Valuation N/A
American Drive Acquisition Co
Price$10.07
Model IV—
P/IV—
Limited data — see page
ADAG
Valuation N/A
Adagene Inc.
Price$4.47
Model IV—
P/IV—
Market implies +49.4%/yr
vs model +2.0% · above model
ADGM
Valuation N/A
Adagio Medical Holdings, Inc.
Price$0.64
Model IV—
P/IV—
Market implies +44.5%/yr
vs model +15.0% · above model
ADIL
Valuation N/A
ADIAL PHARMACEUTICALS, INC.
Price$2.90
Model IV—
P/IV—
Limited data — see page
ADSEW
Valuation N/A
Ads-Tec Energy Public Ltd Co
Price$0.65
Model IV—
P/IV—
Limited data — see page
ADT
Valuation N/A
ADT Inc.
Price$6.83
Model IV—
P/IV—
Limited data — see page
ADTX
Deep Undervalued
Aditxt, Inc.
Price$0.01
Model IV$0.03
P/IV3.91
Discount 83%
Return to IV: +483.1%
ADVB
Valuation N/A
Advanced Biomed Inc.
Price$4.99
Model IV—
P/IV—
Limited data — see page
ADX
Valuation N/A
ADAMS DIVERSIFIED EQUITY FUND, INC.
Price$25.59
Model IV—
P/IV—
Limited data — see page
AEAQ
Valuation N/A
Activate Energy Acquisition Corp.
Price$10.00
Model IV—
P/IV—
Limited data — see page
AEC
Valuation N/A
ANFIELD ENERGY INC.
Price$4.22
Model IV—
P/IV—
Limited data — see page
AEF
Valuation N/A
abrdn Emerging Markets ex-China Fund, Inc.
Price$9.19
Model IV—
P/IV—
Limited data — see page
AEFC
Valuation N/A
AEGON LTD.
Price$18.81
Model IV—
P/IV—
Limited data — see page
AEG
Valuation N/A
AEGON LTD.
Price$8.66
Model IV—
P/IV—
Limited data — see page
AEHL
Valuation N/A
Antelope Enterprise Holdings Ltd
Price$1.00
Model IV—
P/IV—
Limited data — see page
AEI
Valuation N/A
Alset Inc.
Price$1.34
Model IV—
P/IV—
Market implies +35.0%/yr
vs model +2.0% · above model
AEMD
Valuation N/A
AETHLON MEDICAL INC
Price$0.71
Model IV—
P/IV—
Market implies +5.9%/yr
vs model +15.0% · below model
AENTW
Deep Undervalued
ALLIANCE ENTERTAINMENT HOLDING CORP
Price$0.43
Model IV$18.43
P/IV0.03
Discount 98%
Return to IV: +4,181.1%
Market implies -50.0%/yr
vs model +6.0% · below model
AEON
Valuation N/A
AEON Biopharma, Inc.
Price$0.72
Model IV—
P/IV—
Limited data — see page
AERT
Deep Overvalued
Aeries Technology, Inc.
Price$7.34
Model IV$0.65
P/IV1.15
Premium +1,025%
Return to IV: -91.1%
Market implies +29.4%/yr
vs model +15.0% · above model
AERTW
Deep Undervalued
Aeries Technology, Inc.
Price$0.02
Model IV$5.29
P/IV0.00
Discount 100%
Return to IV: +24,619.6%
Market implies -50.0%/yr
vs model +36.6% · below model
AESP
Valuation N/A
Aeon Acquisition I Corp.
Price$9.87
Model IV—
P/IV—
Limited data — see page
AEXA
Valuation N/A
American Exceptionalism Acquisition Corp. A
Price$11.85
Model IV—
P/IV—
Limited data — see page
AEYE
Deep Overvalued
AUDIOEYE INC
Price$6.51
Model IV$4.42
P/IV1.74
Premium +47%
Return to IV: -32.1%
Market implies +8.4%/yr
vs model +13.3% · below model
